• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN LP LLC NORTH HAVEN TRI-STAPLE 2.0; STAPLE, IMPLANTABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN LP LLC NORTH HAVEN TRI-STAPLE 2.0; STAPLE, IMPLANTABLE Back to Search Results
Model Number SIGTRS60AMT
Device Problems Separation Failure (2547); Failure to Form Staple (2579)
Patient Problem No Code Available (3191)
Event Date 03/09/2020
Event Type  Injury  
Manufacturer Narrative
(b)(4).If information is provided in the future, a supplemental report will be issued.
 
Event Description
According to the reporter, during laparoscopy low anterior resection surgery, handle and reload were able to be set without any problems, and there was no problem with the firing, but the anchoring suture was not cut.In addition, regarding the reload, some staples were found to be remained on the tip side, and there was a possibility that the handle did not squeezed until the end.One part of the tissue could not be resected, so additional resection was performed with another reload to deal with the problem.
 
Manufacturer Narrative
Medtronic conducted an investigation based upon all information received.The device was returned for evaluation.Visual inspection identified that it was partially fired to the 1cm cut line.The proximal sutures were cut.The distal cartridge and anvil sutures were still anchored with small pieces of reinforcement material attached.Staple pushers were visible at the 1cm cut line indicating the point where the handle compression had stopped.Functional testing found that when applied to test media, all remaining staples were placed and the media was cleanly transected.The distal sutures were released as the reload was fully fired, and the safety interlock feature successfully prevented the reload from firing a second time.It was reported that the staples did not form properly and the trs material did not release.A related device issue was confirmed.The product analysis noted evidence that the device was not used as intended.This issue can occur if the firing handle has not been completely cycled.If the instrument return knobs are retracted at any point once the firing cycle has begun, the reload will engage into safety interlock and prevent further attempts to fire by ceasing the placement of staples and tissue transection to prevent patient harm.The manufacturing records for each device are also thoroughly reviewed prior to release to ensure that products meet all medtronic quality specifications.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRI-STAPLE 2.0
Type of Device
STAPLE, IMPLANTABLE
Manufacturer (Section D)
COVIDIEN LP LLC NORTH HAVEN
195 mcdermott rd
north haven CT 06473
MDR Report Key9960966
MDR Text Key187687441
Report Number1219930-2020-01738
Device Sequence Number1
Product Code GDW
UDI-Device Identifier10884521543638
UDI-Public10884521543638
Combination Product (y/n)N
PMA/PMN Number
K160176
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,user facility
Type of Report Initial,Followup
Report Date 06/26/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberSIGTRS60AMT
Device Catalogue NumberSIGTRS60AMT
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/26/2020
Initial Date Manufacturer Received 04/01/2020
Initial Date FDA Received04/14/2020
Supplement Dates Manufacturer Received06/10/2020
Supplement Dates FDA Received06/26/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-